| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $18,401,737 ) (Continued on the next page) |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | T32GM148403 | VCU Initiative for Maximizing Student Development Program (IMSD) | 000 | 3 | NIH | 1/24/2025 | $270,995 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01GM124204 | Structural and Mechanistic Insights into AAV Rep Mediated Site-Specific Integration and Packaging | 000 | 8 | NIH | 11/21/2024 | $293,423 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH084894 | Function of GPCR heteromeric complexes in brain | 001 | 15 | NIH | 12/26/2024 | $447,909 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA053153 | Opioid- and HIV-mediated effects on the integrity of the blood-brain barrier, on immune cell recruitment, and on antiretroviral penetration into the brain | 000 | 6 | NIH | 2/25/2025 | $442,098 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DE030667 | Dissecting the role of sialic acid and sialidase in the pathophysiology of Porphyromonas gingivalis | 000 | 5 | NIH | 1/27/2025 | $440,286 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA260819 | A sequential therapeutic strategy of senescence induction and senolytics for elimination of surviving residual breast tumor cells | 000 | 5 | NIH | 3/3/2025 | $465,649 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA239714 | Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia | 001 | 7 | NIH | 2/13/2025 | $0 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA239714 | Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia | 000 | 7 | NIH | 12/27/2024 | $846,622 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA060762 | pTau-related neuron and cognitive dysfunction in opioid-HIV comorbidity: Longitudinal and functional studies | 000 | 2 | NIH | 1/24/2025 | $627,826 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U24NS100673 | SIREN CORE-EM HUB ALLIANCE | 000 | 8 | NIH | 1/20/2025 | $138,040 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | U24NS100673 | SIREN CORE-EM HUB ALLIANCE | 000 | 8 | NIH | 1/20/2025 | $137,858 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01GM143176 | Small molecule approach to activate human SIRT5 | 000 | 4 | NIH | 3/3/2025 | $327,365 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL162991 | Metabolic perturbations in conventional dendritic cells modulate Tfh13 induction in asthmatic sensitization | 000 | 3 | NIH | 11/29/2024 | $540,579 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH124981 | Developmental methylomics of autism spectrum disorder | 000 | 5 | NIH | 2/13/2025 | $585,546 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL163101 | Protein S-Palmitoylation in the Heart: Function and Regulation in Health and Disease | 000 | 3 | NIH | 11/18/2024 | $373,062 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA277437 | Enhancing Tumor Cell Immunogenicity using Improved Molecules Targeting Chromatin Remodeling | 000 | 2 | NIH | 11/14/2024 | $163,199 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DA055825 | Pharmacology of Stimulant Choice | 000 | 3 | NIH | 2/27/2025 | $314,381 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA279255 | Identification of small molecule inhibitors of the DDI2 protease | 000 | 3 | NIH | 3/13/2025 | $629,373 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA259415 | Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma | 000 | 3 | NIH | 12/5/2024 | $381,112 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI174301 | Lentivirus-like particle specific delivery of Cas12 ribonucleoprotein (RNP) to HIV reservoir cells in vivo for an HIV cure | 002 | 3 | NIH | 12/12/2024 | $836,927 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK137998 | An Integrated Lifestyle Intervention to Promote Cardiometabolic Health among Emerging Adult Women | 000 | 2 | NIH | 2/17/2025 | $279,450 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01MH125902 | An Integrative Approach to the Etiology of Internalizing Disorders in the Lifelines Cohort | 000 | 4 | NIH | 11/19/2024 | $470,647 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UG1CA287017 | Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) | 000 | 2 | NIH | 12/5/2024 | $725,460 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01EY033477 | Sustained release of fenofibrate for the treatment of diabetic retinopathy | 000 | 3 | NIH | 1/23/2025 | $23,288 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA272147 | Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms | 000 | 3 | NIH | 3/6/2025 | $563,791 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F32AI174656 | Multifunctional roles of an Orientia tsutsugamushi nucleomodulin | 000 | 2 | NIH | 11/19/2024 | $74,284 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01HL168133 | Antibacterial and Antithrombotic Catheter Lock Solutions Based on Controlled Release of Nitric Oxide | 000 | 3 | NIH | 3/11/2025 | $388,125 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K23HL159270 | The Relationship of Exercise Associated Cardiac Reserve on Peak Oxygen Consumption and Frailty Measures in Individuals Undergoing Allogeneic Hematopoietic Stem Cell Transplant. | 000 | 3 | NIH | 1/24/2025 | $149,048 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AR082365 | Unraveling the Mechanism of Mechanotransduction in Hierarchical Collagen Fiber Formation | 000 | 3 | NIH | 2/14/2025 | $300,078 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R25HL161607 | Undergraduate Cardiovascular Research Program | 000 | 4 | NIH | 1/24/2025 | $123,120 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K99HL173554 | Mechanisms and Efficacy of Physical Activity to Reduce Cardiovascular Morbidity in Women with Breast Cancer | 000 | 1 | NIH | 1/10/2025 | $133,566 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F31DA060668 | Novel Therapeutics for Treating Opioid Use Disorder | 000 | 1 | NIH | 12/10/2024 | $48,974 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21MH138949 | Studying normal and disease processes in brain with extracellular vesicles | 000 | 1 | NIH | 3/11/2025 | $271,688 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA289216 | Inhibition of diacylglycerol lipase α as a novel strategy to mitigate the nephrotoxicity of cisplatin | 000 | 1 | NIH | 12/27/2024 | $227,221 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R36DA062213 | A Mixed Methods Exploration of Prenatal Polysubstance Use | 000 | 1 | NIH | 1/16/2025 | $53,956 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01EB036599 | Ultrasensitive Ion-Selective Optodes for Self-Testing of Blood Electrolytes | 000 | 1 | NIH | 1/22/2025 | $260,467 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21CA296516 | Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy | 000 | 1 | NIH | 11/26/2024 | $181,448 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA290863 | Supportive Tailored Exercise Program for Survivors of Breast Cancer (STEPS-BC) | 000 | 1 | NIH | 1/31/2025 | $671,757 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | K08HL155852 | Targeting Pannexin 1 as a Novel Mechanism for Arrhythmia and Fibrosis in Duchenne Cardiomyopathy | 000 | 5 | NIH | 1/21/2025 | $148,052 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | UH3DA050311 | Mu Opioid Receptor Modulator Development to Treat Opioid Use Disorder | 000 | 5 | NIH | 1/16/2025 | $1,313,983 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | F30MD018324 | The relationship between social needs and primary care use after enrollment in Virginia’s Medicaid expansion: The influence of sociocultural and built environments | 000 | 3 | NIH | 10/29/2024 | $42,911 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R03AI180319 | Enzymology and Structure of Divergent Type 4 Pilus Extension ATPases | 000 | 2 | NIH | 11/25/2024 | $75,296 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01CA285692 | MYCN drives a druggable SUMOylation program in neuroblastoma | 000 | 2 | NIH | 12/20/2024 | $386,821 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R21DE033842 | Connecting liquid-liquid phase separation with super-enhancers and key oncogene transcription in HNSCC | 000 | 2 | NIH | 3/10/2025 | $170,435 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R35GM152058 | Ins and outs of the bioactive sphingolipid metabolite sphingosine-1-phosphate | 001 | 2 | NIH | 12/2/2024 | $349,313 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK121131 | Sensory Cross-Activation in Bowel Dysfunction | 000 | 4 | NIH | 11/27/2024 | $388,707 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01AI167857 | Orientia tsutsugamushi Ank-host interactions in scrub typhus pathogenesis | 000 | 4 | NIH | 1/28/2025 | $555,206 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK107451 | The role of AEG-1 in NASH and NASH-HCC | 001 | 8 | NIH | 12/20/2024 | $41,044 |
| | 2025 | 2025 | VIRGINIA COMMONWEALTH UNIVERSITY | 910 WEST FRANKLIN ST | RICHMOND | VA | 23284-9005 | RICHMOND CITY | USA | R01DK107451 | The role of AEG-1 in NASH and NASH-HCC | 000 | 8 | NIH | 12/19/2024 | $543,969 |
|
